160 related articles for article (PubMed ID: 15216449)
1. Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes.
Jacob S; Klimm HJ; Rett K; Helsberg K; Häring HU; Gödicke J
Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):315-22. PubMed ID: 15216449
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
[TBL] [Abstract][Full Text] [Related]
3. MARRIAGE: A Randomized Trial of Moxonidine
Valensi P; Jambart S
J Cardiovasc Pharmacol Ther; 2024; 29():10742484241258381. PubMed ID: 38828542
[TBL] [Abstract][Full Text] [Related]
4. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
6. Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics.
Lozano JV; Llisterri JL; Aznar J; Redon J;
Nephrol Dial Transplant; 2001; 16 Suppl 1():85-9. PubMed ID: 11369830
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients.
Mancia G; Omboni S; Agabiti-Rosei E; Casati R; Fogari R; Leonetti G; Montemurro G; Nami R; Pessina AC; Pirrelli A; Zanchetti A
J Cardiovasc Pharmacol; 2000 Jun; 35(6):926-31. PubMed ID: 10836728
[TBL] [Abstract][Full Text] [Related]
9. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
[TBL] [Abstract][Full Text] [Related]
11. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Ruilope LM; Usan L; Segura J; Bakris GL
J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
[TBL] [Abstract][Full Text] [Related]
12. Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
Derosa G; Ragonesi PD; Mugellini A; Ciccarelli L; Fogari R
Hypertens Res; 2004 Jul; 27(7):457-64. PubMed ID: 15302981
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.
Wong GW; Boyda HN; Wright JM
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007451. PubMed ID: 26961574
[TBL] [Abstract][Full Text] [Related]
14. Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial.
Masajtis-Zagajewska A; Majer J; Nowicki M
Hypertens Res; 2010 Apr; 33(4):348-53. PubMed ID: 20139920
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Holzgreve H; Nakov R; Beck K; Janka HU
Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of a fixed-dose combination of metoprolol extended release/amlodipine in patients with mild-to-moderate hypertension: a randomized, parallel-group, multicentre comparison with losartan plus amlodipine.
Pareek A; Chandurkar NB; Sharma R; Tiwari D; Gupta BS
Clin Drug Investig; 2010; 30(2):123-31. PubMed ID: 20067330
[TBL] [Abstract][Full Text] [Related]
17. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
Sharma AM; Wagner T; Marsalek P
J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
[TBL] [Abstract][Full Text] [Related]
18. Effects of sympatholytic therapy on insulin sensitivity indices in hypertensive postmenopausal women.
Kaaja R; Kujala S; Manhem K; Katzman P; Kibarskis A; Antikainen R; Ylihärsilä H; Erkkola R; Tuomilehto J
Int J Clin Pharmacol Ther; 2007 Jul; 45(7):394-401. PubMed ID: 17725246
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
